Marshall Wace
ZURA icon

Marshall Wace’s Zura Bio ZURA Stock Holding History

Marshall Wace’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-852,340
Closed -$5.07M – 3831
2026
Q1 		$5.07M Sell
852,340
-25,423
-3% -$154K 0.01% 1298
2025
Q4 		$4.6M Buy
877,763
+610,563
+229% +$2.41M ﹤0.01% 1193
2025
Q3 		$1.16M Buy
+267,200
New +$481K ﹤0.01% 1877
2023
Q1 		– Sell
-486,402
Closed -$4.97M – 3172
2022
Q4 		$4.97M Hold
486,402
– – 0.01% 1192
2022
Q3 		$4.89M Hold
486,402
– – 0.01% 1385
2022
Q2 		$4.84M Hold
486,402
– – 0.01% 1367
2022
Q1 		$4.82M Buy
486,402
+204,882
+73% +$2.02M 0.01% 1403
2021
Q4 		$2.78M Buy
+281,520
New +$2.78M 0.01% 1830

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Marshall Wace's ZURA Position: Q2 2026 in Review

Marshall Wace sold out of Zura Bio (ZURA) in Q2 2026, closing a stake of 852,340 shares — an estimated $5.07M sold.

Marshall Wace first reported a position in ZURA in Q4 2021 and held it in 8 quarters. The position peaked at $5.07M in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Marshall Wace reported no remaining Zura Bio position as of Q2 2026 after selling out during the quarter.
  • Marshall Wace sold 852,340 Zura Bio shares in Q2 2026, an estimated $5.07M.
  • Marshall Wace first reported a position in Zura Bio in Q4 2021 and held it in 8 quarters.
  • Marshall Wace's Zura Bio position peaked at $5.07M in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.